VITO AIELLO, Italy
ASP PALERMO DIABETES UNIT- PARTINICO CIVIC HOSPITALAuthor Of 1 Presentation
OP098 - DIABCOVID A NEW TYPE OF DIABETES FOLLOWING SARS COV2 INFECTION? (ID 825)
Abstract
Background and Aims
During the SARS COV 2 pandemic, the number of cases of unrecognized diabetes increased in those hospitalized for pneumonia. It has been hypothesized that some forms of diabetes not classified as classic are attributable to SARS COV 2 infection.
Methods
We studied the prevalence of diabetes in those admitted to our Covid Hospital from January 2021 to September 2022. A total of 1200 subjects studied by cross-analysis of hospital discharge forms with diabetes mellitus and final therapy as research item.
Results
The prevalence of diabetes mellitus was 2.16%. Of the subjects diagnosed with diabetes, 26.9% were not classifiable as type 1 or type 2 and the condition of diabetes mellitus was not previously known. HbA1c values were not statistically (7,8 ± 0,95 vs 8,1 ± 1,1 p=NS) different among subjects with diabetes and autoimmune markers were not present. Fasting C-peptide levels (ng/ml) were significantly lower (0,8 ± 0,23 vs 2,3 ±0,8 p <0.05) in those with not previously known diabetes, 57.2% were discharged on insulin therapy. and continued it after 92 ± 18 days of follow-up.
Conclusions
The interrelationship between COVID-19 and diabetes remain uncertain and researchers hope to understand whether Covid-19 causes a new form of diabetes or more simply a stress response that triggers classic diabetes. In our experience those individuals with fasting C-peptide levels lower than usual obeserved in Type 2 diabetic subjects continued insulin theraphy for a limited time. They could be a new entity of diabetes classification but longitudinal data are further required to confirm what we can call DIabCovid.